162 related articles for article (PubMed ID: 12212356)
21. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
22. Thyrotoxicosis: a rare presenting symptom of Hurthle cell carcinoma of the thyroid.
Wong CP; AuYong TK; Tong CM
Clin Nucl Med; 2003 Oct; 28(10):803-6. PubMed ID: 14508269
[TBL] [Abstract][Full Text] [Related]
23. Hurthle cell tumor.
Chen HY; Benjamin LB; Chen MF
Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
[TBL] [Abstract][Full Text] [Related]
24. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
Maxwell EL; Palme CE; Freeman J
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
[TBL] [Abstract][Full Text] [Related]
25. Hurthle cell neoplasm of the thyroid gland.
Sidhu S
ANZ J Surg; 2008 Mar; 78(3):115. PubMed ID: 18269467
[No Abstract] [Full Text] [Related]
26. Surgery for thyroid Hürthle cell tumours--a single institution experience.
Paunovic I; Krgovic K; Tatic S; Diklic A; Zivaljevic V; Kalezic N; Havelka M
Eur J Surg Oncol; 2006 May; 32(4):458-61. PubMed ID: 16497473
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
Perigli G; Cicchi P; Cianchi F; Artusi R; Olivari D; Caldini A; Cortesini C
J Exp Clin Cancer Res; 1998 Mar; 17(1):113-6. PubMed ID: 9646245
[No Abstract] [Full Text] [Related]
28. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
29. [Follicular carcinoma and Hürthle cell tumor of the thyroid].
Miccoli P; Arganini M
Chir Ital; 1994; 46(4):29-32. PubMed ID: 7882439
[TBL] [Abstract][Full Text] [Related]
30. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
[TBL] [Abstract][Full Text] [Related]
31. Hürthle cell tumors of the thyroid gland. Personal experience and review of literature.
Bononi M; De Cesare A; Cangemi V; Fiori E; Galati G; Giovagnoli MR; Izzo L; Cimitan A; Meucci M; Cavallaro A
Anticancer Res; 2002; 22(6B):3579-82. PubMed ID: 12552959
[TBL] [Abstract][Full Text] [Related]
32. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
[TBL] [Abstract][Full Text] [Related]
33. Thyroid Hürthle cell carcinoma metastatic to the pituitary gland.
Fabiano AJ; Qiu J; Rigual N
Thyroid; 2012 Apr; 22(4):442. PubMed ID: 22376169
[No Abstract] [Full Text] [Related]
34. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
35. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature.
Tranchida P; Estigarribia J; Sethi S; Giorgadze T
Diagn Cytopathol; 2011 Sep; 39(9):641-6. PubMed ID: 20949456
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
37. Metastatic Hürthle cell carcinoma: a unique case report and review of the literature.
Khan S; Sharibi A; Neff R; Grace W; Young IS
Endocr Pract; 2005; 11(4):285-9. PubMed ID: 16006295
[No Abstract] [Full Text] [Related]
38. [Hurthle cell neoplasm: our experience].
Cristofaro MG; Vescio G; Fava MG; Aversa C; Amantea M; Giudice M
Ann Ital Chir; 2004; 75(6):663-8. PubMed ID: 15960361
[TBL] [Abstract][Full Text] [Related]
39. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
McHenry CR; Sandoval BA
Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
[TBL] [Abstract][Full Text] [Related]
40. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
